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Midbrain dopamine (DA) neurons are involved in cognition, control of motor activity, and emotion-
related behaviors. Degeneration of DA neurons particularly in the substantia nigra is a hallmark
of Parkinson’s disease. The homeobox transcription factor, Pitx3, plays a critical role in the
development, function, and maintenance of midbrain DA neurons. We found that in young adult
Pitx3-null mice, Pitx3(/), there was decreased tyrosine hydroxylase staining, indicating a loss of DA
neurons particularly in the substantia nigra. In addition, fast-scan cyclic voltammetry and microdialysis
assays of DA release indicated that the lack of Pitx3 caused a signiﬁcant reduction of striatal DA release.
Tonic DA release was impaired more signiﬁcantly than the phasic DA release induced by burst ﬁring of
DA neurons. Furthermore, behavioral tests revealed that Pitx3(/) mice displayed abnormal motor
activities, including impaired motor coordination and decreased locomotion. In summary, these data
provide further evidence that Pitx3 is speciﬁcally required for DA-related function and, if impaired, Pitx3
could contribute during the pathogenesis of Parkinson’s disease.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Midbrain dopamine (DA) neurons play an essential role in the
control of motor activity and other behaviors related to emotion
and cognition. Degeneration of these neurons, especially in the
substantia nigra compacta (SNc), causes Parkinson’s disease (PD),
which is a severe neurological disease primarily characterized by
DA dysfunction in the nigrostriatal system (Braak et al., 2003;
Jellinger, 2012; Li et al., 2009; Simon et al., 2003).
Several transcription factors regulate the differentiation of
midbrain DA neuron precursors. Nurr1, a member of the Nur77/
NGFI-B subfamily of the nuclear receptor superfamily of transcrip-
tion factors, is strongly implicated in the growth, maintenance, and
survival of DA neurons. Mice harboring null alleles of Nurr1 do not
express tyrosine hydroxylase (TH) (Bafﬁ et al.,1999; Eells et al., 2001;
Kimet al., 2003; Le et al.,1999; Sakurada et al.,1999),which catalyzes
the initial step of DA neurotransmitter biosynthesis. Furthermore,
mice deﬁcient in Nurr1(þ/) show a rapid onset of age-relatedience, Mahoney Institute for
ity of Pennsylvania, Philadel-
-0833.
Inc. This is an open access article udecline in DA signaling that precedes the signiﬁcant loss of DA
neurons (Zhang et al., 2012). Another factor, LIM homeobox tran-
scription factor 1 beta (LMX1B), contributes partially to the speciﬁ-
cation of DA neuronal progenitors beginning on embryonic day 12.5
in the mouse, but LMX1B is not essential for TH gene expression
(Smidt et al., 2000). A third transcription factor, the bicoid-related
homeodomain-containing transcription factor, Pitx3, plays an
important roles in the development, function, and maintenance of
midbrain DA neurons (Andersson et al., 2006; Li et al., 2009;Wallen
and Perlmann, 2003). Pitx3 is expressed in the SNc and the ventral
tegmental area (VTA) DA neurons (Smidt et al., 1997; Zhao et al.,
2004). However, the lack of Pitx3 results in the preferential loss of
the SNc neuronal subpopulation whereas the VTA neurons remain
relatively intact, a phenotype that closely resembles that of PD
(Hwang et al., 2003;Maxwell et al., 2005; Smidt et al., 2004; van den
Munckhof et al., 2003). Moreover, Pitx3 directly regulates the
expression of a cascade of molecules in DA neurons, including TH,
Vmat2, En1, brain-derived neurotrophic factor, and glial cell-derived
neurotrophic factor, indicating that Pitx3 expression is important for
the function of adultmidbrainDAneurons (Kimet al., 2014;Maxwell
et al., 2005; Peng et al., 2007, 2011; Yang et al., 2008).
To further identify the biological functions of Pitx3 in the
midbrain DA system, we used the Pitx3-null (Pitx3/) mice to
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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associated with the decline of motor activities. In the present study,
we report that Pitx3-lacking mice (3e5 months in age) showed a
loss of DA neurons mainly in the SNc, as revealed by the loss of TH-
positive staining. In addition, fast-scan cyclic voltammetry and
microdialysis assays of DA signaling indicated that the lack of Pitx3
caused signiﬁcant reduction of striatal DA release. Associated with
the loss of DA neurons and DA signaling there were motor-activity
deﬁcits, including impaired motor coordination and decreased
locomotion. In summary, these data provide direct evidence that
the lack of Pitx3 caused DA neuron loss, decreased DA signaling, and
contributed to deﬁcits in locomotor activities.
2. Methods
2.1. Pitx3-null mutant mice
Pitx3 heterozygous null mice (Pitx3þ/) were kindly provided
by Professor Beeler, Department of Neurobiology, The University of
Chicago, Chicago, IL, USA. The mice were inbred and expanded at
the transgenic animal center of Baylor College of Medicine. The
siblings of the inbred mice were analyzed for their genotypes
through the restriction enzyme digestion of polymerase chain re-
action product from mouse tail extracted DNA. We used 3- to 5-
month-old Pitx3 homozygous null mice for our experiments and
their wild-type littermates as controls with the same genetic
background for the behavioral and anatomy experiments. Because
the Pitx3(/) mice displayed a dramatic decrease in DA release
beginning in the early ages (3e5 months) and there was not a
dramatic age-associated decline shortly beyond that age group, we
grouped data from mice at 3e5 months of age when examining DA
release with fast-scan cyclic voltammetry. Mice were housed and
handled in accordance with the guidelines approved by the animal
care committee at Baylor College of Medicine.
2.2. Behavioral assessment of Pitx3(/) mice
The behavioral performance of Pitx3(/) or their wild-type
littermates was evaluated using the rotarod test and the locomo-
tor activity test. Motor coordination was determined with an
accelerating rotarod treadmill (Columbus Instruments, Columbus,
OH, USA). Initially, each mouse was required to perch on the sta-
tionary rod for 30 seconds to accustom itself to the environment.
Then the animals were trained at a constant speed of 5 rpm for
90 seconds. After this training session, the mice were tested 3 times
at 1-hour intervals on 3 consecutive days for a total of 9 tests.
During each test, the rotarod was set at a starting speed of 5 rpm for
30 seconds, and the speed was increased by 0.1 revolution per
second. All animals were tested 3 times for each experiment, and
the means of the test results underwent statistical analysis. Loco-
motive activities were carried out from9 AM to 11 AM in a relatively
dark room, and the behavioral performance was monitored by the
AccuScan Digiscan system (AccuScan Instruments, Inc, Columbus,
OH, USA). Data collected by computer included total distance
traveled (centimeter per 60minutes) andmoving time (seconds per
60 minutes). Each mouse was placed in the testing chamber for
30 minutes for adaptation, followed by a 60-minute recording by
the computer-generated automatic analysis system.
2.3. Tyrosine hydroxylase immunohistochemistry
Mice were transcardially perfused with ice-cold phosphate-
buffered saline (PBS) (pH 7.4), and the central part of the striatum
and the midbrain were dissected for DA biochemistry and TH im-
munostaining. The midbrains were ﬁxed, rapidly frozen, andsectioned into 30-mm slices. The slices were systematically chosen
at 150-mm intervals. Free-ﬂoating sections were incubated succes-
sively for 15 minutes with 0.05% H2O2 in 0.1-M PBS to remove
endogenous peroxidase activity for 1 hour with 2% goat serum per
0.1% Triton X-100 in 0.1-M PBS to block nonspeciﬁc binding sites
and for 24 hours at 4 C with the primary anti-TH antibody (rabbit,
1:4000; Protos Biotech, New York, NY, USA) to detect DA neurons.
After washing, sections were then incubated for 2 hours at a routine
time with the appropriate biotinylated secondary antibody (anti-
rabbit, 1:200; Vector Laboratories Inc, Burlingame, CA, USA). The
avidin-biotin method was used to amplify the signal (ABC Kit;
Vector Laboratories Inc) and 3,3’-diaminobenzidine tetrachloride
was used to visualize bound antibodies.
We used stereological methods to evaluate the number of
TH-positive DA neurons in the SNc using a stereological system
(Axioskop 2; Carl Zeiss Inc, Thornwood, NY, USA). Counting was
performed with the computer-assisted stereological toolbox soft-
ware program, Stereo Investigator 7.0 (MicroBrightField, Inc,
Willston, VT, USA). The substantia nigra was outlined under
2.5 magniﬁcation, and 50% of the outlined region was analyzed
using a sampling design generated with the following stereologic
parameters: grid size, 200  200 mm; counting frame size,
150  150 mm; and dissector height, 14 mm.
2.4. Determination of striatal DA content
The concentration of DA in the striatal tissue was quantiﬁed by
high-performance liquid chromatography (HPLC). We made coro-
nal sections. Although avoiding the ventral striatum that contains
the nucleus accumbens, we selected themiddle part of the striatum
by dissection. Then that tissue was homogenized (10% wt/vol) by
sonication in ice-cold 0.1-M perchloric acid. Homogenates were
centrifuged at 10,000 g for 10 minutes at 4 C, and the supernatant
was collected and ﬁltered through acro-disc ﬁlters (0.25 mm; Fisher
Scientiﬁc, Pittsburgh, PA, USA) and subjected to HPLC (HTEC-500;
Eicom, Kyoto, Japan) with the SC-3ODS column (EICOMPAK; Eicom,
Kyoto, Japan) and detected by an electrochemical detector (AD In-
struments Pty Ltd, Castle Hill, New South Wales, Australia). The
mobile phase consisted of 0.1-mM citric acid, 0.1-M sodium acetate,
220-mg/L octane sulfate sodium, 5-mg/L EDTA, and 20% methanol.
The pH was adjusted to 3.5.
2.5. Fast-scan cyclic voltammetric measurement of DA signals from
striatal brain slices
A combination of ketamine, xylazine, and acepromazine was
used to achieve deep anesthesia before mice were decapitated and
the brains were rapidly removed. Horizontal slices (350 mm) were
cut on a vibratome, and they were incubated at 32  0.5 C for
30 minutes (Zhou et al., 2001). Then the slices were held at room
temperature for>30 minutes, and they were studied at 34 1 C in
artiﬁcial cerebrospinal ﬂuid: 125-mM NaCl, 2.5-mM KCl, 1.3-mM
MgCl2, 2.5-mM CaCl2, 26-mM NaHCO3, 1.25-mM NaH2PO4, and
10-mM glucose, saturated with 95% O2 and 5% CO2.
Carbon-ﬁber microelectrodes (10-mm diameter and approxi-
mately 100 mm exposed length; P55s, Amoco Polymers, Greenville,
SC, USA) were used to perform fast-scan cyclic voltammetry within
themiddle portion of the dorsolateral striatum (Zhang et al., 2009a;
Zhou et al., 2001). The carbon-ﬁber microelectrode potential was
linearly scanned at 10 Hz from 0 to 400 to 1000 to 400 to 0 mV
against a silver-silver chloride reference electrode at a rate of
300 mV/ms. The data were acquired and analyzed using an Axo-
patch 200B ampliﬁer, a Digidata1320 interface, and a pClamp 8
system (Axon Instruments Inc, Union City, CA, USA). The back-
ground current was subtracted digitally from the voltammograms,
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currents was at roughly 600 mV for DA, and each voltammogram
was converted into a DA concentration based on a post-
experimental calibration of the carbon-ﬁber electrode against
fresh solutions of 0.5e10 mM DA.
A bipolar tungsten electrode was used to deliver intrastriatal
stimuli. The poles of the stimulating electrode were about 150 mm
away from each other, and the tip of the carbon-ﬁber recording
microelectrode was about 200 mm away from each of the 2 poles of
the stimulating electrode. Different stimulation protocols were
used, and phasic burst stimulations were applied at an intraburst
frequency of 20 Hz based on our previous in vivo unit recordings of
DA neuron bursts from freely moving rats (Zhang et al., 2009b).
Each stimulus pulse was 1 ms in duration and about 0.6 mA at
constant current. Unless trains of stimuli were applied, isolated
stimuli were separated by 2 minutes to allow recovery of the DA
release.
The electrically stimulated DA response was measured as the
peak amplitude (mM) or was measured as the area under the curve
of DA concentration (mM-s). The phasic and/or tonic relative DA
signal was calculated by comparing the burst evoked DA signal to
the single-pulseeevoked DA signal. The results are presented as the
means  standard error of the mean. Two-way analysis of variance
was used to judge the changes in frequency-dependent DA release
between genotypes.2.6. In vivo microdialysis and HPLC for DA quantiﬁcation
Microdialysis was performed as described previously (Dong
et al., 2010; Zhang et al., 2012). Guide cannulae (CMA/7) (CMA/
Microdialysis, Solna, Sweden) were aimed at the dorsal striatum.
That is, we avoided the ventral striatum containing the nucleus
accumbens while placing the probe in the middle of the striatum.
The probe was not in the extreme dorsal area but rather more
central in location. The stereotaxic coordinates (relative to bregma)
were 0.38-mm anteroposterior, 2.0-mm lateral, and 2.5-mm
dorsal-ventral, and the post-microdialysis anatomy found all the
probes within the striatum indicated in Fig. 3C (Paxinos and
Franklin, 2001). We allowed 3e5 days of recovery from surgery.
At least 14 hours before the experiment, the probe was positioned
and microdialysate buffer (149-mM NaCl, 2.8-mM KCl, 1.2-mM
CaCl2, 1.2-mM MgCl2, and 0.25-mM ascorbic acid, 5.4-mM D-
glucose) was perfused at 0.5 mL/min overnight and, then, 2.0-mL/
min beginning at least 1 hour before baseline sampling.
The DA content of microdialysates was determined by HPLC:
pump (Model 582; ESA, Inc, Chelmsford, MA, USA), autosampler
(Model 542; ESA, Inc), and an HR-80  3.2 mm column (3-mm
particle size; ESA Inc). A coulometric cell (5014B; ESA, Inc) wasFig. 1. Behavioral assessment of Pitx3(/) mice. Behavior activity was evaluated by the tim
Data were expressed as means  standard error of the mean. *p < 0.05, **p < 0.01 versusconnected to an ESA Coulochem II detector. Quantiﬁcation of dial-
ysate DA concentrationwas estimated relative to external standards
(0e2 nM). The slope and the y-intercept were calculated for the
standard curve, and then the microdialysate concentration was
interpolated from the regression by using the slope-intercept
equation.3. Results
3.1. Rotarod and locomotor performance of Pitx3(/) mice
Both rotarodperformanceand locomotive activities of Pitx3(/)
mice and theirwild-type littermateswere evaluated. Comparedwith
their wild-type littermates, Pitx3(/) mice showed a poorer
rotarod performance, as shown by their reduced time on the rotarod
(Fig. 1A). The time spent on the rod was 58.7% (p < 0.01, n¼ 6e7 for
each group) less in Pitx3(/) than wild-type mice. In addition, the
locomotive activities (total distance traveled andmoving time) were
also signiﬁcantly decreased (Fig. 1B and C, p < 0.05, n ¼ 6e7 for
each group). The total distance traveled and the moving time in
Pitx3(/) micewere 41.3% (p< 0.05) and 44.8% (p< 0.05) less than
wild-type mice. Compared with the wild-type control mice, the
Pitx3(/) mice displayed a signiﬁcantly poorer locomotor
performance.3.2. TH-positive neurons in SNc and striatal DA levels in Pitx3(/)
mice
The number of TH-positive DA neurons in the substantia nigra of
Pitx3(/) and wild-type (control) mice was determined with an
unbiased stereological optical dissector using the Cavalieri principle
(Pakkenberg et al., 1991). The number of TH-positive neurons in the
SNc of Pitx3(/) mice was signiﬁcantly reduced (Fig. 2A): 470 
68 versus 3462  535, data from 6 Pitx3-null mice and 5 control
mice, p < 0.001 (Fig. 2B). The decrease in TH-positive neurons was
smaller in the VTA of these relatively young Pitx3(/) mice
compared with controls (Fig. 2C): 3507  449 versus 4090  502,
data from 6 Pitx3-null mice and 5 control mice, p > 0.05.
The main target of DA projections from the SNc is the dorsal
striatum. Therefore, tissue from the central portion of the dorsal
striatum was homogenized, and the concentrations of DA and its
metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homo-
vanillic acid were measured. Consistent with the TH cell counts,
Pitx3(/) mice showed a signiﬁcant decline of DA content
compared with control mice (n ¼ 5e6 mice, p < 0.05, Table 1) as
shown by a decreased DA concentration and unchanged ratios of
DOPAC/DA and homovanillic acid/DA. Furthermore, the 5-HT
metabolism was not signiﬁcantly altered (Table 1).e the mice stayed on a rotating rod (A), total distance traveled (B), and moving time (C).
wild type.
Fig. 3. Decreased evoked dopamine (DA) release in striatal slices from Pitx3(/)
mice. In horizontal brain slices, DA release was evoked by a single electrical stimulus
pulse, and the extracellular DA concentration in the dorsal striatum was measured
using fast-scan cyclic voltammetry. (A) The magnitude of the DA response; (B) the area
under the DA concentration curve (mM s). (C) The post-microdialysis anatomy found
all the probes were within the dorsal striatum (CPu ¼ caudate putamen) as indicated
by the black bars (Paxinos and Franklin, 2001). (D) An analysis by high-performance
liquid chromatography of the microdialysis samples provided the DA concentrations
of freely moving mice. *p < 0.05, **p < 0.01 versus wild-type mice.
Fig. 2. Immunostaining and quantitative analysis of dopamine neurons in the
midbrain. (A) Representative photomicrographs of midbrain TH immunohistochem-
istry (10). (B) The relative TH immunopositive neurons in the SNc. Each value was
presented as the mean  standard error of the mean based on the number of TH
immunopositive neurons relative to wild-type control mice. **p < 0.001 versus wild
type (C). The relative TH immunopositive neurons in the VTA. Abbreviations: SNc,
substantia nigra compacta; TH, tyrosine hydroxylase; VTA, ventral tegmental area.
Table 1
Concentration of monoamines
Catecholamine Wild type (ng/mg) Pitx3(/) (ng/mg)
DA 6.47  0.31 3.58  0.29**
DOPAC 1.86  0.25 0.98  0.31*
HVA 0.89  0.09 0.64  0.08
5-HT 1.19  0.21 1.12  0.19
5-HIAA 0.52  0.03 0.42  0.03
*p < 0.05 versus wild-type control mice.
**p < 0.01 versus wild-type control mice.
Key: DA, dopamine; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, serotonin.
W. Le et al. / Neurobiology of Aging 36 (2015) 3314e3320 33173.3. Reduced DA release from Pitx3(/) mice in the striatum
Because Pitx3 is particularly important for the development of
DA neurons in the SNc, we examined electrically evoked DA release
in the dorsal striatum, which is innervated overwhelmingly by the
SNc. In horizontal brain slices, DA release was evoked by a single
electrical stimulus pulse (600 mA, 1 ms), and the real-time extra-
cellular DA concentration in the dorsal striatum was measured
using fast-scan cyclic voltammetry (Zhang et al., 2009a; Zhou et al.,
2001). The magnitude of the DA response (Fig. 3A) was quantiﬁed
by measuring the peak amplitude (mM) and the area under the DA
concentration curve (mM s), which is plotted in Fig. 3B. The mean
peak amplitude of the single-pulseeevoked DA signal was 92%
smaller in Pitx3(/) mice compared with control mice: 0.09 
0.01 mM (n¼ 21) in Pitx3(/) mice and 1.12 0.11 mM (n¼ 28, p<
0.001) in age-matched wild-type control mice. The area under the
curve subsumes factors arising from the amplitude of the DA
release and the rate of DA removal by diffusion and DA transporter
reuptake (Schmitz et al., 2003; Zhang et al., 2009a). The DA signal,
as measured by the area under the curve, was also signiﬁcantly
different between the genotypes (Fig. 3B). This result indicates that
the removal of DA from the extracellular space did not sufﬁciently
compensate for the decreased release in the Pitx3(/) mice.
The cyclic voltammetry measurements (including Fig. 3A and B)
examine only the evoked DA release exclusively in the DA target
area, the dorsal striatum. To examine the overall function of the
intact DA system projection from the midbrain SNc to the middle of
the striatum (within the dorsal striatum), we measured the basal
DA concentration using in vivo microdialysis in freely moving mice.
The range of the placement of the microdialysis probes within the
dorsal striatum is indicated in Fig. 3C (black bars). Although the
basal DA concentrationwas signiﬁcantly different (Fig. 3D) between
the wild-type control mice (4.0 0.6 nM, n¼ 7) and the Pitx3(/)
mice (2.2  0.4 nM, n ¼ 8, p < 0.05), the difference was not as greatas that seen when measuring evoked DA release with voltammetry
(Fig. 3B). This difference, between Fig. 3B and D, may arise in part
because the microdialysis probe sampled a much broader area,
including more ventral portions of the dorsal striatum where DA
release is not as strongly inﬂuenced by the Pitx3 genotype. To es-
timate the apparent concentration of DA in the extracellular space,
the no-net-ﬂux method of quantitative microdialysis was applied
(Justice, 1993). This background concentration of extracellular DA
was again smaller in the Pitx3 deﬁciency mice: 19.7  0.7 nM, (n ¼
7, p < 0.05) in the Pitx3(/) mice and 27.1  0.5 nM in the wild-
type control mice. The results indicated decreased DA signaling to
the dorsal striatum in Pitx3-null mice.3.4. Tonic and phasic DA signaling in Pitx3(/) and wild-type
mice in the dorsal striatum
Although the DA release in the Pitx3(/) mice is severely
impaired in the dorsal striatum to a 1-pulse stimulus, DA release
also responds biologically to phasic bursts. Therefore, we examined
the phasic versus tonic DA release by providing isolated 1-pulse
Fig. 5. Application of stimulus trains to measure dopamine (DA) release under more
realistic biological activity using fast-scan cyclic voltammetry. (AeD) The stimulus train
was a 2.5 Hz tonic train that was allowed to reach pseudoesteady state before we
began recording the DA signal arising from 4-pulses at 2.5 Hz, a 3-pulse burst, 3 single
stimuli, 5-pulse burst, and 2 single stimuli. These stimulus trains are indicated under
each recording: (A) example control, wild-type mouse, (B) example Pitx3(/) mouse,
(C) averaged control, (D) averaged Pitx3(/). The standard errors of the mean are
indicated by the line gray traces that mirror the dark average traces in (C) and (D). (E)
The area under the curve is plotted for the single stimuli (1p), for the 3-pulse burst
(3p), and for the 5-pulse burst (5p). *p < 0.05, **p < 0.01 versus wild type.
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frequency was applied at 20 Hz to match the approximate average
burst frequency we have previously measured in freely moving
rodents (Zhang et al., 2009b). In this case, the 1-pulse and 5-pulse
bursts were applied in isolation, separating the individual stimuli
by 2 minutes. For the control case (Fig. 4A, control), the phasic burst
causes a slightly larger DA release than the single pulse, consistent
with previous results in the dorsal striatum (Zhang et al., 2009a). In
the Pitx3(/) mice, the phasic 5-pulse stimulation causes a rela-
tively larger increase in the DA release. This increase in phasic
release relative to the single pulse can be seen by normalizing the
Pitx3 1-pulse DA release to the DA release produced in the control
case (Fig. 4B). When the ratio of phasic to 1-pulse DA release are
compared for the control and the Pitx3(/) case, the ratio is
signiﬁcantly larger (p < 0.01) in the Pitx3 case (Fig. 4B and C).
To more closely approximate the biological condition, the phasic
bursts have to be applied along with ongoing tonic activity (Exley
and Cragg, 2008; Zhang et al., 2009a). Rodent DA neurons ﬁre at
an average rate of about 4 Hz (Clark and Chiodo, 1988; Grace and
Bunney, 1984; Hyland et al., 2002; Zhang et al., 2009b). The ﬁring
activity includes background tonic activity with superimposed
phasic bursts that are thought to represent salient events encoun-
tered in the environment. To explore how the loss of Pitx3 in-
ﬂuences tonic versus phasic DA release under more biologically
relevant conditions, we applied various stimulus trains and
measured DA signals using fast-scan cyclic voltammetry. To mimic
background tonic signaling, we applied stimuli at 2.5 Hz, and we
represented phasic signaling by including bursts of 3 and 5 pulses at
20 Hz. The average of the stimulus train was 4 Hz to match the
average ﬁring observed in vivo, and the burst frequencywas applied
at 20 Hz to match the approximate average burst frequency we
have measured in freely moving rodents (Zhang et al., 2009b).
The actual stimulus train (Fig. 5)was a 2.5-Hz tonic train thatwas
allowed to reach pseudoesteady state before we measured the DA
signal arising from 4-pulses at 2.5 Hz (Fig. 5AeD). Then, the train
included a 3-pulse burst, 2 tonic pulses, a 5-pulse burst, endingwith
2 tonic stimulus pulses (Fig. 5AeD). An example recording was
shown of the DA release recorded from a striatal slice taken from a
control (Fig. 5A) and a Pitx3(/) (Fig. 5B) mouse, and the averaged
data with indicated standard error of the mean are shown below
(Fig. 5C and D). In both the control (Fig. 5A,C) and the Pitx3(/)
(Fig. 5B,D), the phasic bursts increased DA release beyond the tonic
DA concentration plateau. The phasic bursts, however, were more
effective in elevating the DA release from the Pitx3(/) tissue
relative to the tonic background. As the applied phasic bursts
became longer (i.e., 5-pulse burst), theDAsignal fromthePitx3(/)
approached that seen in thewild-type control striatal slices (Fig. 5E).Fig. 4. Tonic and phasic DA signaling in Pitx3(/) and wild-type mice in the dorsal
striatum. (A) Examples of a single stimulus (1p, solid traces) and a 20 Hz, 5-pulse burst
stimulus (5p, dashed traces) are shown for a wild-type (control) and Pitx3-null mouse.
(B) The traces for the Pitx3-null mouse (right traces of panel A) are normalized to the
amplitude of the control (left traces of panel A) to reveal the greater relative phasic DA
release in Pitx3 nulls. (C) The averaged data for the normalized ratio of phasic to 1p DA
release. **p < 0.01 versus wild type. Abbreviation: DA, dopamine.With tonic stimulation (2.5 Hz), the DA signal in Pitx3(/) was
about 40% of the control, but during the 5-pulse phasic burst, the DA
signal in Pitx3(/) was about 75% of the control (Fig. 5E).3.5. DA signal changes in the ventral striatum of Pitx3-null mice
The Pitx3(/) mice have the most severe DA neuron loss in the
SNc, which projects much more strongly to the dorsal than ventral
striatum (van Domburg and ten Donkelaar, 1991; Zhou et al., 2002).
However, the DA projections to the ventral striatum also are
compromised, and we examined DA release in the ventral striatum
using fast-scan cyclic voltammetry (Fig. 6). Themagnitude of the DA
response to a 1-pulse stimulus (Fig. 6A) was quantiﬁed by
measuring the peak amplitude (mM): 0.25  0.05 mM (n ¼ 21) in
Pitx3(/) mice and 0.39  0.05 mM (n ¼ 8, p < 0.05) in control
mice. We also measured the area under the DA concentration curve
(mM  s), which is plotted in Fig. 6B. The DA signal was smaller in
ventral striatum from the Pitx3(/) mice, 60% of the control based
on the area under the DA curve (Fig. 6B), but the decreasewas not as
large as observed in the dorsal striatum, which was 10% of the
dorsal striatum control (Fig. 3B).
To examine how the loss of Pitx3 inﬂuences tonic versus phasic
DA release in the ventral striatum under more biologically relevant
conditions, we applied the same stimulus train used to study the
dorsal striatum. We applied stimuli at 2.5 Hz, and we represented
phasic signaling by including bursts of 3 and 5 pulses at 20 Hz
(Fig. 6C and D). The averaged recordings (Fig. 6C and D) with
indicated standard error of the mean show that the DA signal is
Fig. 6. Dopamine (DA) signal changes in the ventral striatum of Pitx3-null mice. The DA
release in the ventral striatum was determined using fast-scan cyclic voltammetry. (A)
Example traces showing the magnitude of the DA response to a 1-pulse stimulus from a
Pitx3(/) slice (black trace) or from a wild-type slice (control, gray trace). (B) The area
under the DA concentration curve (mM  s) is plotted for control and Pitx3(/). (C and
D) Using the same stimulus train (indicated below the traces) as was used for the dorsal
striatum, here the average data from the ventral striatum are shownwith standard error
of the mean indicated. *p < 0.05 versus wild type.
W. Le et al. / Neurobiology of Aging 36 (2015) 3314e3320 3319smaller in the Pitx3(/) mice. The results quantitatively differed
between the ventral and dorsal striatum. With tonic stimulation
(2.5 Hz), the ventral striatumDA signal in Pitx3(/) was about 63%
of the control (Fig. 6C and D). During the 5-pulse phasic burst, the
ventral DA signal in Pitx3(/) was about 61% of the control (Fig. 6C
and D). The results indicate that with this stimulation pattern both
tonic and phasic DA release are comparably decreased in the ventral
striatum of Pitx3(/) mice.
4. Discussion
We found that Pitx3-null mice (3e5 months of age) show loss of
TH expression associated with the loss of midbrain DA neurons.
This decline was also observed as decreased striatal DA release and
abnormal motor activities, suggesting that Pitx3 expression is
critical for the health and functions of adult midbrain DA neurons.
Previous studies have indicated that Pitx3-null mice have selective
loss of A9 DA neurons in the midbrain and have shown impaired
performance on motor coordination tasks (Hwang et al., 2003;
Nunes et al., 2003). In this study, we also found decreased loco-
motor activities and impaired motor coordination compared with
wild-type control mice. We also documented a striking decrease of
DA neuron numbers in the SNc but only a slight decrease in the VTA
in the Pitx3-null mice. The greater sensitivity and smaller sampling
area of the carbon-ﬁber fast-scan cyclic voltammetry measure-
ments indicated decreased DA release was muchmore severe in the
dorsal striatum, which is innervated mainly by the SNc. However,
there was still a signiﬁcant decrease in evoked DA release in the
ventral striatum, which receives the vast major of its innervation
from the VTA. These data support the notion that Pitx3 selectively
controls proper development and maintenance of midbrain DA
neurons, and those effects are seen most potently in the A9 DA
neurons and the nigrostriatal pathway.
The quantitative differences in DA release between the dorsal
and ventral striatum arising from innervation mainly from the SNcand VTA (respectively) may contribute to the quantitative differ-
ences measured with carbon-ﬁber voltammetry (Fig. 3B) versus
microdialysis (Fig. 3D). These 2 approaches measure different as-
pects of DA release and, thus, should not be expected to show
quantitatively identical results. Among their differences is that
carbon-ﬁbers are small and sample from a volume in the tens of mm
(per side) range while microdialysis samples from a volume in the
hundreds of mm (per side) range. That quantitative difference in DA
release (between Fig. 3B and D) may arise in part because the
microdialysis probe samples a wider volume that will average the
middle of the striatum, including the more ventral portions. Those
more ventral areas of the striatum are expected to have a smaller
decrease in DA signaling (arising from the Pitx3[/] genotype)
owing to a less severe loss of DA neurons in the VTA versus the SNc
(Fig. 2). Thus, the Pitx3(/) genotype is expected to show a
gradient inﬂuence of DA release with the greatest decrease in DA
release observed in the most dorsal extremes.
The development and function of midbrain DA neurons requires
complex changes in transcriptional processes regulating gene
expression (van den Munckhof et al., 2003). Pitx3 may play roles in
these transcriptional regulatory events, thereby, supporting
mechanisms for changes in transcription during the development
and function of midbrain DA neurons. The proper functioning of
transcription factors requires the appropriate timing and dosage of
activity (Smidt et al., 1997). For example, the successful generation
of DA neurons from mouse embryonic stem cells using a Nestin-
enhancer-Lmx1a construct suggests that precise dosage and
timing of Lmx1a are essential for the differentiation of DA neurons
from immature cells (Andersson et al., 2006). The present study
highlights the importance of the transcription factor, Pitx3, for the
health and function of DA neurons.
Although there is some controversy, there is evidence that Pitx3
is involved in neurodegenerative diseases and, thereby, potentially
provides a target for therapeutic strategies. Pitx3 genetic variants
have been identiﬁed in PD patients in several reports (Bergman
et al., 2010; Fuchs et al., 2009; Gui et al., 2012; Le et al., 2011; Liu
et al., 2011) but not in all studies (Cai et al., 2011). In general,
functional studies and some genetic analysis suggest the Pitx3-
based transcriptional network and its regulation of the nigral DA
neurons may contribute to neuronal development and survival.
Those Pitx3-involved molecular mechanisms likewise may provide
new therapeutic targets to slow or avert the degenerative decline of
DA neurons during PD for a small subset of patients.
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